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Despite persistent exposure to microbial agents, the nail 
unit appears to be capable of ensuring efficient innate 
immune defence. In the human nail, antimicrobial pep-
tides (AMPs), which are small molecules with a broad 
spectrum of innate defence properties, may play an im-
portant role (1, 2). Although the specific arrangement of 
the nail’s immune components is poorly understood, one 
could speculate that a well-developed immune defence 
may require the correct expression and localization of 
AMPs. Nevertheless, the exact contribution of AMPs 
both in homeostasis and disease has yet to be defined. 
In psoriatic skin plaques, the levels of several AMPs are 
reported to be highly upregulated (3). Furthermore, AMPs 
of the cathelicidin and defensin groups are suggested to be 
decisive players in psoriasis pathogenesis (3, 4). Hence, 
based on data from plaque psoriasis studies, one could 
hypothesize AMP upregulations in nails with psoriasis and 
that AMP upregulation would result in decreased secon-
dary infections. However, in nail psoriasis, an increased 
coincidence of onychomycosis has been reported (5, 6).
Because the exact consequences of psoriatic inflam-
mation in the nail unit are unknown and might differ 
from the ones described in the skin (7), we evaluated the 
AMP profile in the human nail apparatus. Specifically, 
we determined the presence and distribution of AMPs of 
the cathelicidin (LL-37) and beta defensin (hβD-2, hβD-3 
and hβD4) groups in psoriatic nail apparatus specimens 
and compared them to clinically normal nails.
METHODS
The patient group with nail psoriasis included 20 patients (18 to 
70 years of age). Nail unit tissue specimens (5 mm in diameter) 
were obtained from the nail bed using a punch biopsy technique. 
Inclusion criteria were: i) a clinical diagnosis of nail psoriasis 
with nail bed involvement (8, 9); ii) a pathohistological diagnosis 
of nail psoriasis (8).
For the control group, 26 necropsies from human cadaver nail 
units (nail bed and nail matrix) were obtained (within 12 h of the 
death) and included for further evaluation. Only nail apparatuses 
with normal clinical and pathohistological appearance were in-
cluded in the study. Exclusion criteria for both groups included: i) 
the presence of any disease in the medical history that might affect 
nails (except psoriasis in the psoriatic nail group); ii) a positive 
Periodic acid-Schiff (PAS) reaction and/or fungal culture of the 
nail sample; iii) history of any local or systemic anti-bacterial, 
anti-fungal, anti-inflammatory, immunosuppressive, or immuno-
modulating treatment received within the last month.  
Immunohistochemistry. Four µm sections of paraffin-embedded 
nail biopsy specimens were treated with antibodies for LL-37 
(rabbit; 1:200; Biorbyt, UK), hβD-2 (goat; 1:100; Bio-Techne, 
UK), hβD-3 (rabbit; 1:1000; Novus Biologicals, USA) and hβD-4 
(mouse; 1:100; Santa Cruz Biotechnology, USA) (10). Immu-
nostaining was assessed semi-qantitatevly by grading the stained 
cells in the visual field (11). Non-parametric statistics using the 
Mann-Whitney U-test display the ranking differences between the 
control group and studied group.
RESULTS
In both the psoriatic and control groups, we observed 
LL-37 positive cells; however, more positive cells were 
present in nail psoriasis samples. In psoriasis-affected 
nails, numerous (+++) positive cells were observed in the 
epithelial layer of the nail bed. Interestingly, in the control 
group, only moderate (++) numbers of LL-37 positive 
cells were present (Fig. 1 a and b; Table I). Further, in 
the control group samples, LL-37 immunoreactivity was 
evenly distributed throughout the nail unit, including 
proximal and distal nail matrixes.
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Fig. 1. Detection of antimicrobial 
peptides by immunohisto chemistry in 
psoriatic nail beds (a, c, e) compared 
to controls (b, d, f). (a) Abundance of 
LL-37-positive cells in the psoriatic nail 
bed and (b) a moderate number of LL-
37 positive cells in the control nail bed; 
numerous and moderate numbers of hBD-2 
positive cells were observed in psoriatic (c) 
and control nail beds (d); numerous hBD-3 
positive cells were detected in psoriatic (e) 
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In psoriatic nails, cells positive for hβD-2 and hβD-
3 were observed in nail bed epithelia. The number of 
positive cells varied from numerous (+++) to abundant 
(++++) in the visual field (Fig. 1 c and e). Moderate 
(++) numbers of hβD-2 and hβD-3 positive cells were 
found in the control group’s nail bed (Fig. 1 d and f) and 
a patchy distribution of positive cells was observed near 
the nail plate. In contrast, in psoriatic nails, expression 
was evenly distributed throughout the nail bed. Notably, 
more hβD-2 and hβD-3 positive cells were observed per 
visual field of the psoriatic nail samples. Cells positive 
for hβD-4 staining were not observed in either psoriatic 
and control group nails (Table I).
DISCUSSION
In our study, all nail specimens affected by chronic 
psoriatic inflammation had significantly more LL-37, 
hβD-2 and anti-hβD- 3 positive cells when compared 
to the control group samples. These findings are con-
sistent with previously described increases in AMPs in 
psoriatic skin lesions, particularly LL-37 and hβD-2, 
by other authors (2, 4). Moreover, the role for LL-37 
as an autoantigen in psoriasis patients is supported by 
the presence of cytokine-producing LL-37-specific T 
cells found in plaque psoriasis (4, 12). However, to our 
knowledge, the expression and distribution of AMPs in 
nail units affected by psoriasis have not been previously 
described. Therefore, taking into account the observed 
increase in the number of LL-37 positive cells in psoriatic 
nails in our study, we suggest that LL-37 is characteristic 
for nail psoriasis. Furthermore, we speculate that LL-37 
may be of particular importance not only for inducing the 
psoriasis-related inflammation but also for the persistence 
of psoriasis-related inflammation in nail unit due to either 
excessive and/or perpetual exposure of the nail apparatus 
to microbial and fungal agents. 
We observed LL-37 positive cells throughout the heal-
thy control group’s nail bed as well as both proximal and 
distal matrixes. Previously, LL-37 and hβD-2 have been 
reported in the healthy nail apparatus (1, 13). Further, 
we found that expression of hβD-2 and hβD-3 in control 
nails was predominantly found at sites directly exposed 
to fungal and microbial agents such as the nail plate. 
These findings suggest that, along with LL-37, AMPs of 
the defensin group are expressed in the healthy human 
nail unit. Importantly, we provide evidence that AMPs 
in the nail apparatus might contribute to the relative im-
mune privilege of the nail matrix (14). AMPs expressed 
in the nail apparatus may help to promote an effective 
defence in the presence of continuous exposure to various 
microbiologic agents.
Additionally, we propose that the perceived coincidence 
of psoriasis and onychomycosis might be over estimated. 
Despite the lack of cellular immune components in 
the nail plate, nail units may ensure defence against 
infections by upregulating the expression of AMPs. 
Furthermore, we suggest that the elevated numbers of 
hβD-2 and hβD-3 positive cells in the nail apparatus of 
people affected by psoriasis may also contribute to the 
specific expression pattern of AMPs. By determining the 
distinctive expression pattern of AMPs in human nails 
affected by psoriasis, we can enhance our understanding 
of psoriatic nail disease and rationally develop targeted 
treatment options to interfere with AMPs, while avoiding 
unnecessary immunosuppressive consequences.
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Table I. Detection of LL-37, hβD-2, hβD-3, and hβD-4 in psoriasis-
affected and control nail bed by immuno histochemistry
Antibody Psoriasis Control p
LL-37 ++++ ++ < 0.001
hβD-2 +++ ++ < 0.001
hβD-3 +++ ++ < 0.001
hβD-4 None None 1
*p-significance of difference between psoriasis and control nail beds (Mann-
Whitney U test). Designation of semi-quantitative grading: + few; ++ moderate 
numbers; +++ numerous numbers; ++++ abundant positive cells for staining 
in the visual field.
